Showing the promising results of these approaches, anti-BAG3 and anti-PD1 treatment with targeted antibodies in a mouse model reduced pancreatic tumor volume along with an increase in CD8+ T cells [184]. This evidence concerns the gene BAG3 and pancreatic neoplasm.